Kyle Guse

Atossa Genetics

Chief Financial Officer, General Counsel and Secretary

Overview

Kyle Guse made an average of $871.9K in compensation at Atossa Genetics from 2013 to 2018.

Annual data

2018

In 2018, Kyle Guse earned a total compensation of $905.3K as Chief Financial Officer, General Counsel and Secretary at Atossa Genetics.

Ranking7,844 out of 10,998
Percentile28.7%

Kyle Guse's 2018 compensation ranked 7,844th out of 10,998 executive pay records tracked by us this year.

Guse earned more than 28.7% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking945 out of 1,265
Percentile25.3%

In the industry group of Drugs, Guse's pay ranked 945th out of 1,265 executive pay records tracked by us in 2018.

Guse earned more than 25.3% of executives in this group.

Non-Equity Incentive Plan$150,000
Option Awards$329,006
Salary$408,000
Other$18,325
Total$905,331

Guse received $408K in salary, which accounts for 45.07% of total compensation.

Guse also received $150K in non-equity incentive plan, $329K in option awards and $18.3K in other compensation.

2017

In 2017, Kyle Guse earned a total compensation of $735.7K as Chief Financial Officer, General Counsel and Secretary at Atossa Genetics.

Ranking9,809 out of 13,798
Percentile28.9%

Kyle Guse's 2017 compensation ranked 9,809th out of 13,798 executive pay records tracked by us this year.

Guse earned more than 28.9% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,076 out of 1,568
Percentile31.4%

In the industry group of Drugs, Guse's pay ranked 1,076th out of 1,568 executive pay records tracked by us in 2017.

Guse earned more than 31.4% of executives in this group.

Non-Equity Incentive Plan$163,800
Option Awards$195,919
Salary$364,000
Other$12,000
Total$735,719

Guse received $364K in salary, which accounts for 49.48% of total compensation.

Guse also received $163.8K in non-equity incentive plan, $195.9K in option awards and $12K in other compensation.

2016

In 2016, Kyle Guse earned a total compensation of $783.9K as Chief Financial Officer, General Counsel and Secretary at Atossa Genetics.

Ranking9,366 out of 14,043
Percentile33.3%

Kyle Guse's 2016 compensation ranked 9,366th out of 14,043 executive pay records tracked by us this year.

Guse earned more than 33.3% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking982 out of 1,500
Percentile34.5%

In the industry group of Drugs, Guse's pay ranked 982nd out of 1,500 executive pay records tracked by us in 2016.

Guse earned more than 34.5% of executives in this group.

Non-Equity Incentive Plan$170,000
Option Awards$239,311
Salary$364,000
Other$10,600
Total$783,911

Guse received $364K in salary, which accounts for 46.43% of total compensation.

Guse also received $170K in non-equity incentive plan, $239.3K in option awards and $10.6K in other compensation.

2015

In 2015, Kyle Guse earned a total compensation of $808K as Chief Financial Officer, General Counsel and Secretary at Atossa Genetics.

Ranking8,901 out of 13,589
Percentile34.5%

Kyle Guse's 2015 compensation ranked 8,901st out of 13,589 executive pay records tracked by us this year.

Guse earned more than 34.5% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking985 out of 1,485
Percentile33.7%

In the industry group of Drugs, Guse's pay ranked 985th out of 1,485 executive pay records tracked by us in 2015.

Guse earned more than 33.7% of executives in this group.

Non-Equity Incentive Plan$131,040
Option Awards$302,325
Salary$364,000
Other$10,600
Total$807,965

Guse received $364K in salary, which accounts for 45.05% of total compensation.

Guse also received $131K in non-equity incentive plan, $302.3K in option awards and $10.6K in other compensation.

2014

In 2014, Kyle Guse earned a total compensation of $746.2K as Chief Financial Officer, General Counsel and Secretary at Atossa Genetics.

Ranking8,765 out of 12,932
Percentile32.2%

Kyle Guse's 2014 compensation ranked 8,765th out of 12,932 executive pay records tracked by us this year.

Guse earned more than 32.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking867 out of 1,316
Percentile34.1%

In the industry group of Drugs, Guse's pay ranked 867th out of 1,316 executive pay records tracked by us in 2014.

Guse earned more than 34.1% of executives in this group.

Non-Equity Incentive Plan$149,625
Option Awards$236,190
Salary$350,000
Other$10,400
Total$746,215

Guse received $350K in salary, which accounts for 46.90% of total compensation.

Guse also received $149.6K in non-equity incentive plan, $236.2K in option awards and $10.4K in other compensation.

2013

In 2013, Kyle Guse earned a total compensation of $1.3M as Chief Financial Officer, General Counsel and Secretary at Atossa Genetics.

Ranking5,616 out of 12,080
Percentile53.5%

Kyle Guse's 2013 compensation ranked 5,616th out of 12,080 executive pay records tracked by us this year.

Guse earned more than 53.5% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking397 out of 1,102
Percentile64.0%

In the industry group of Drugs, Guse's pay ranked 397th out of 1,102 executive pay records tracked by us in 2013.

Guse earned more than 64.0% of executives in this group.

Non-Equity Incentive Plan$85,500
Option Awards$941,716
Salary$225,000
Total$1,252,216

Guse received $941.7K in option awards, which accounts for 75.20% of total compensation.

Guse also received $85.5K in non-equity incentive plan and $225K in salary.